Patents by Inventor George Freeman
George Freeman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11992692Abstract: This document describes an automated external defibrillator comprising a control configured to switch between a pediatric operating mode and an adult operating mode, wherein each operating mode comprises a mode-specific energy configuration and a mode-specific user configuration; an indicator configured to provide an indication of the operating mode in use during a resuscitation process; one or more processors configured to switch to the mode-specific energy configuration and the mode-specific user configuration upon a change of operating mode between the pediatric operating mode and the adult operating mode such that the automated external defibrillator delivers a defibrillating shock to a patient based on the mode-specific energy configuration; and an interface of the automated external defibrillator provides resuscitation instructions to a user based on the mode-specific user configuration.Type: GrantFiled: December 14, 2021Date of Patent: May 28, 2024Assignee: ZOLL Medical CorporationInventors: Melissa M. Dascoli, Charles E. Sawyer, Jr., Bill Gastrock, Dustin Boutet, Gary A. Freeman, James Wilson, Brian Stonecipher, Ian Durrant, George Reilly, Mark Bates
-
Patent number: 11931087Abstract: A tissue collection and processing system for collecting bone fragments and tissue aspirated from a bone. The tissue collection and processing system includes a collection vessel, a collection vessel cap, a processing piston, a first tubing and a fluid withdrawal mechanism. The collection vessel has an opening formed therein to receive bone fragments and tissue aspirated from the bone. The collection vessel cap is capable of engaging the collection vessel to substantially seal the opening. The collection vessel cap or the collection vessel has a first port. The processing piston has an upper surface and a lower surface. The processing piston has a connection port and a bore. The connection port is proximate the upper surface. The bore is fluidly connected to the connection port and extends toward the lower surface. The processing piston has a density that is less than a density of fluid in the aspirated bone fragments and tissue.Type: GrantFiled: May 11, 2022Date of Patent: March 19, 2024Assignees: ForCyte Medical, LLC, The Cleveland Clinic FoundationInventors: Robert Assell, Andy Freeman, George Muschler
-
Patent number: 11837108Abstract: This invention relates to a computer-implemented simulation system comprising a needle device having a retractable needle shaft comprising a resistance mechanism which can be activated to vary the resistance of the needle shaft. A processing module is configured to: receive ultrasound image data representative of a subject being scanned, receive position and orientation data representative of an ultrasound probe and a needle device, calculate a projected path for the needle device and generate a simulation needle from the projected path. When the simulation needle is determined to intersect with an identified tissue type, it modulates a signal and sends the modulated signal to the resistance mechanism, thereby to cause a change in the resistive force acting on the retractable needle shaft. The invention also relates to a computer-implemented method for simulating ultrasound guided needling using this system.Type: GrantFiled: May 5, 2020Date of Patent: December 5, 2023Inventors: Nicholas James Sleep, Stephen Margetts, Wesley George Freeman
-
Publication number: 20220230561Abstract: The present disclosure relates to a computer-implemented simulation system comprising a needle device having a retractable needle shaft comprising a resistance mechanism which can be activated to vary the resistance of the needle shaft, an ultrasound probe configured to transmit an ultrasound beam, a display unit and a processing module. The invention disclosure also relates to a computer-implemented method for simulating ultrasound guided needling using this system.Type: ApplicationFiled: May 5, 2020Publication date: July 21, 2022Inventors: Nicholas James SLEEP, Stephen MARGETTS, Wesley George FREEMAN
-
Patent number: 9487419Abstract: A method for treating acid mine drainage includes mixing acid mine drainage (20) and alkaline tailings from a gold recovery process (140). The acid mine drainage is thereby neutralized (12).Type: GrantFiled: March 12, 2013Date of Patent: November 8, 2016Assignee: MINTAILS MINING S A (PTY) LIMITEDInventors: Jan Hendrik Phillipus Jacobs, Robert George Freeman
-
Patent number: 9319428Abstract: A method and system for analyzing scripts. A script is analyzed to determine whether the script includes malicious content. A computer executes at least two text blocks of code derived from a script of a web page. The execution of a text block of the at least two text blocks generates an additional text block of code. The computer determines whether the additional text block includes new code that is malicious. If so, the computer prevents transmission of the web page to a client computer. If not, the computer transmits the web page to the client computer.Type: GrantFiled: June 20, 2012Date of Patent: April 19, 2016Assignee: International Business Machines CorporationInventor: Robert George Freeman
-
Publication number: 20150041404Abstract: A method for treating acid mine drainage includes mixing acid mine drainage (20) and alkaline tailings from a gold recovery process (140). The acid mine drainage is thereby neutralized (12).Type: ApplicationFiled: March 12, 2013Publication date: February 12, 2015Applicant: MINTAILS MINNING SA (PTY) LIMITEDInventors: Jan Hendrik Phillipus Jacobs, Robert George Freeman
-
Publication number: 20120260338Abstract: A method and system for analyzing scripts. A script is analyzed to determine whether the script includes malicious content. A computer executes at least two text blocks of code derived from a script of a web page. The execution of a text block of the at least two text blocks generates an additional text block of code. The computer determines whether the additional text block includes new code that is malicious. If so, the computer prevents transmission of the web page to a client computer. If not, the computer transmits the web page to the client computer.Type: ApplicationFiled: June 20, 2012Publication date: October 11, 2012Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATIONInventor: Robert George Freeman
-
Patent number: 8214903Abstract: A method and system for analyzing scripts. A script is processed, which executes text blocks of code derived from the script and copied to an output file in a sequential order. The script is the first text block that is copied to the output file. Executing the text blocks includes interpreting each text block to generate and execute a corresponding interpreted block of code. Processing the script results in the text blocks being sequenced in the output file in the sequential order. The text blocks include an original text block of code that includes text that may be directly inferred from text appearing in the script. The blocks of code include a new text block of code, which includes text that may not be directly inferred from text appearing in the script. The new text block is generated from executing the original text block.Type: GrantFiled: October 2, 2009Date of Patent: July 3, 2012Assignee: International Business Machines CorporationInventor: Robert George Freeman
-
Publication number: 20110083183Abstract: A method and system for analyzing scripts. A script is processed, which executes text blocks of code derived from the script and copied to an output file in a sequential order. The script is the first text block that is copied to the output file. Executing the text blocks includes interpreting each text block to generate and execute a corresponding interpreted block of code. Processing the script results in the text blocks being sequenced in the output file in the sequential order. The text blocks include an original text block of code that includes text that may be directly inferred from text appearing in the script. The blocks of code include a new text block of code, which includes text that may not be directly inferred from text appearing in the script. The new text block is generated from executing the original text block.Type: ApplicationFiled: October 2, 2009Publication date: April 7, 2011Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATIONInventor: Robert George Freeman
-
Publication number: 20100326369Abstract: A pet toy is provided that includes an elongated body portion defining an inner cavity portion. The elongated body portion is provided with an exterior plush-like fabric material. A secondary pet toy, such as a dog bone, is disposed in the inner-cavity portion of the elongated body portion.Type: ApplicationFiled: June 25, 2009Publication date: December 30, 2010Inventors: George Freeman, Richard Shiu
-
Patent number: 7257471Abstract: A communications device is provided for routing a locomotive over a track layout in a train yard. The locomotive is operable over a plurality of alternative track routes to reach a respective destination from a plurality of possible destinations in said track layout. The track layout includes a plurality of switches configured to alter a route for a locomotive running along the track layout. The communications device may include a first user display for use in commanding a desired destination for the locomotive within the track layout by setting the state of the switches along the route to the destination.Type: GrantFiled: January 14, 2005Date of Patent: August 14, 2007Assignee: General Electric CompanyInventors: David Kornick, Robert James Foy, Eric B. Moore, John Welsh McElroy, Chris Luevano, George Freeman
-
Publication number: 20050228552Abstract: A communications device is provided for routing a locomotive over a track layout in a train yard. The locomotive is operable over a plurality of alternative track routes to reach a respective destination from a plurality of possible destinations in said track layout. The track layout includes a plurality of switches configured to alter a route for a locomotive running along the track layout. The communications device may include a first user display for use in commanding a desired destination for the locomotive within the track layout by setting the state of the switches along the route to the destination.Type: ApplicationFiled: January 14, 2005Publication date: October 13, 2005Inventors: David Kornick, Robert Foy, Eric Moore, John McElroy, Chris Luevano, George Freeman
-
Publication number: 20050023417Abstract: A holding device that is adapted to fit within the opening of a refuse bag to hold the refuse bag open, and a grasping device that is effective to grasp leaves and other debris to load the leaves and other debris into the refuse bag are provided. The holding and grasping devices are particularly effective in that they increase the efficiency of filling standard refuse bags with leaves, sticks, grass, and other debris since the holder maintains the bag in an open position while the grasper is used to load leaves into the bag.Type: ApplicationFiled: July 31, 2003Publication date: February 3, 2005Inventors: Kelson Burns, George Freeman
-
Patent number: 6413938Abstract: According to a first aspect of the invention there is provided compounds of formula (I): wherein: R1 is hydroxy; O-acetyl; or a halo atom; R2 is hydroxy; O-acetyl; or a halo atom; R3 is hydrogen; a halo atom; azido; C2-6alkenyl; C2-6alkynyl; C6-14aryl C2-6alkenyl; C6-14arylC2-6alkynyl —NR8R9 (where R8 and R9 may be the same or different and are hydrogen, C1-8alkyl, cyanoC1-8alkyl, hydroxyC1-8alkyl, haloC1-8alkyl, C3-7cycloalkyl, C1-8alkylC3-7cycloalkyl, C2-6alkenyl, C3-7cycloalkylC1-8alkyl, C2-6alkynyl, C6-14aryl, C6-14arylC1-8alkyl, heterocycleC1-8alkyl, C1-8alkylcarbonyl, C6-14arylsulfonyl, C1-8alkysulfonyl, or R8R9 together with the N atom to which they are attached form a 3,4,5 or 6 membered heterocyclic ring); —OR10 (where R10 is hydrogen, C1-8alkyl, C6-14aryl, or C6-14arylC1-8alkyl, C2-6alkenyl, C2-6alkynyl, C6-14aryl C2-6alkenyl or C6-14arylC2-6alkynyl); or —SR11 (where R11 is hydrogen, C1-8alkyl, C6-14aryl, or C6-14arylC1-8alkyl).Type: GrantFiled: August 25, 1999Date of Patent: July 2, 2002Assignees: The Regents of the University of Michigan, Glaxo Wellcome Inc.Inventors: Jeffrey H. Tidwell, Stanley D. Chamberlain, George A. Freeman, Joseph H. Chan, George W. Koszalka, Leroy B. Townsend, John C. Drach
-
Patent number: 5840743Abstract: This invention pertains to nucleoside analogs which have antiviral activity and improved metabolic stability. More specifically, this invention pertains to modified sugar benzimidazole nucleosides, as exemplified by compounds such as benzimidazole nucleosides possessing a fluorinated sugar-like moiety (for example, a 2'-fluoro-furanosyl moiety or a 3'-fluoro-furanosyl moiety), and may be represented by the following formula, ##STR1## wherein R.sup.1 is a fluorinated sugar-like moiety; and R.sup.2, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 are benzimidazole substituents, such as --H, halogens (e.g., --F, --Cl, --Br, --I), --NO.sub.2, --NR.sub.2 (where R is independently --H or an alkyl group having 1-6 carbon atoms), --OR (where R is --H or an alkyl group having 1-6 carbon atoms), --SR (where R is --H or a hydrocarbyl of 1-10 carbon atoms), and --CF.sub.3. In one embodiment, R.sup.1 is 2'-fluoro-furanosyl or 3'-fluoro-furanosyl; R.sup.2 is --H, --F, --Cl, --Br, --I, or --NR.sub.Type: GrantFiled: January 22, 1997Date of Patent: November 24, 1998Assignees: The Regents of the University of Michigan, Glaxo Wellcome Inc.Inventors: Leroy B. Townsend, John C. Drach, George A. Freeman
-
Patent number: 5153318Abstract: The present invention relates to 3'-azido purine nucleosides and their use in medical therapy, particularly for the treatment of human immunodeficiency virus and hepatitis B virus infections, to methods for their preparation and to compositions containing them.Type: GrantFiled: October 2, 1990Date of Patent: October 6, 1992Assignee: Burroughs Wellcome Co.Inventors: Janet L. Rideout, George A. Freeman, Steven A. Short, Merrick R. Almond, Jon L. Collins
-
Patent number: 5064946Abstract: Several novel 3-azido-2,3-dideoxy-.beta.-D-erythro-pentofuranosyl derivatives of substituted pyrimidinones having antiretroviral, especially anti-AIDS, activity are described.Type: GrantFiled: December 20, 1989Date of Patent: November 12, 1991Assignee: Burroughs Wellcome Co.Inventors: Sammy R. Shaver, George A. Freeman, Janet L. Rideout
-
Patent number: 5041543Abstract: A compound 1-(3-azido-2,3-dideoxy-.beta.-D-erythro-pentofuranoxyl)-5-methyl-2(1H)-pyr imidinone and its use in a method of generating (forming, providing) 3'-azido-3'-deoxythymidine (zidovudine sometimes referred to as AZT) in the body of an animal (a mammal such as human) by systemically administering 1-(3-azido-2,3-dideoxy-.beta.-D-erythro-pentofuranosyl)-5-methyl-2(1H)-pyr iminone to said animal (mammal such as a human) is disclosed. AZT is approved and used for treating HIV infections, e.g., AIDS and ARC in humans and also has activity against gram-negative bacteria in animals.Type: GrantFiled: September 16, 1988Date of Patent: August 20, 1991Assignee: Burroughs Wellcome Co.Inventors: Sammy R. Shaver, George A. Freeman, Janet L. Rideout
-
Patent number: 4874751Abstract: Treatment of susceptible gram-negative infections in animals is disclosed using the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof.Also disclosed is the use of the 5'-mono-, di- and triphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof for the same purpose.Type: GrantFiled: December 2, 1988Date of Patent: October 17, 1989Assignee: Burroughs Wellcome Co.Inventors: Lowrie M. Beacham, III, Harry S. LeBlanc, George A. Freeman